Ads
related to: pharmaceuticals- Healthcare ETF
Direxion Daily Healthcare ETF
Bull 3X Shares ETF - CURE
- Bull & Bear 3X ETFs
Fixed Income, International Equity
Market Cap And Sector Equity
- ETF Line-up
View Direxion's Complete List of
Leveraged and Inverse ETFs.
- ETF Education
View Our Educational Library to
Learn More About Our Products.
- Healthcare ETF
Search results
Dynamic Technology Lab Private Ltd Takes Position in Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN)
ETF DAILY NEWS· 12 hours agoDynamic Technology Lab Private Ltd purchased a new stake in shares of Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN – Free Report) in the fourth quarter, according to the company ...
Cook County jury rules Zantac not the cause of Brookfield woman's colon cancer
Chicago Sun-Times· 2 hours agoCook County jurors declined to find two pharmaceutical companies responsible for an elderly Brookfield woman’s colon cancer. Lawyers laid out two starkly different arguments ...
Wingspire Completes $12MM Financing Arrangement for Pharmaceutical Company
Monitor Daily· 9 hours agoWingspire Equipment Finance completed a $12 million equipment financing arrangement for a ...
Analyst Report: Jazz Pharmaceuticals plc
Morningstar Research via Yahoo Finance· 21 hours agoJazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across ...
Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Rating Reaffirmed by JPMorgan Chase & Co.
ETF DAILY NEWS· 16 hours agoSyndax Pharmaceuticals (NASDAQ:SNDX – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at JPMorgan Chase & Co. in a note issued to investors ...
Teva Pharmaceutical Indus's Options Frenzy: What You Need to Know - Teva Pharmaceutical Indus...
Benzinga· 1 day agoLoading... Loading... Investors with a lot of money to spend have taken a bearish stance on Teva Pharmaceutical Indus TEVA . And retail traders should know. We noticed this ...
Guest opinion: Don't break the life-sciences industry - San Francisco Business Times
The Business Journals· 47 minutes agoThe last discovery of a new class of antimicrobials that reached the market was in 1987. If Washington doesn't change its ways, we could face similar challenges in the development of drugs to ...
Harnessing RNAi: Alnylam’s Path From Lab Discovery to Life-Changing Treatments
SciTechDaily· 7 hours agoAlnylam Pharmaceuticals, founded by MIT professors and former postdocs, has developed five...
Judge Allows Henrietta Lacks' Family To Continue Legal Action Against Ultragenyx
Black Enterprise· 5 hours agoIn what has been labeled a historic decision, a federal judge has granted the family of Henrietta...
Surprise: Eli Lilly Is Racing Toward Yet Another Blockbuster
Motley Fool via Yahoo Finance· 9 hours agoEli Lilly (NYSE: LLY) can't stop grabbing headlines. The pharmaceutical company has made quite a bit...
Ad
related to: pharmaceuticals
